XML 37 R22.htm IDEA: XBRL DOCUMENT v3.25.4
Stock Plans
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock Plans
Note 13. Stock Plans

Under our 2024 Performance Incentive Plan (the “2024 PIP”), we are authorized through May 21, 2034 to issue a maximum of 50.7 million shares of our Common Stock. As of December 31, 2025, there were 47.0 million shares available to be granted.

Stock Compensation Plans

Stock Options
We recorded compensation expense related to stock options held by our employees of $27 million in 2025, $30 million in 2024 and $25 million in 2023 in our results from continuing operations. The deferred tax benefit recorded related to this compensation expense was $3 million in 2025, $5 million in 2024 and $4 million in 2023. The unamortized compensation expense related to our employee stock options was $19 million at December 31, 2025 and is expected to be recognized over a weighted-average period of 1.6 years.

Our weighted-average Black-Scholes Model fair value assumptions were:
 Risk-Free
Interest Rate
Expected LifeExpected
Volatility
Expected
Dividend Yield
Fair Value
at Grant Date
20254.06%6 years22.52%3.09%$12.63
20244.21%5 years20.93%2.33%$15.23
20234.18%5 years20.97%2.32%$13.57

The risk-free interest rate represents the constant maturity U.S. government treasuries rate with a remaining term equal to the expected life of the options. The expected life is the period over which our employees are expected to hold their options. Volatility reflects historical movements in our stock price for a period commensurate with the expected life of the options. The dividend yield reflects the dividend yield in place at the time of the historical grants.

Stock option activity is reflected below:
Shares Subject
to Option
Weighted-
Average
Exercise or
Grant Price
Per Share
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Balance at January 1, 202320,490,250 $46.31 $417  million
Granted
2,476,320 65.39 
Exercised (1)
(3,894,213)39.59 $123  million
Canceled
(394,237)59.41 
Balance at December 31, 202318,678,120 49.96 $420  million
Granted
2,297,630 73.03 
Exercised (1)
(4,096,571)43.30 $121  million
Canceled
(400,010)63.40 
Balance at December 31, 202416,479,169 54.51 $135  million
Granted
2,025,000 65.13 
Exercised (1)
(2,258,520)42.59 $49  million
Canceled
(523,730)67.18 
Balance at December 31, 202515,721,919 57.17 5 years$55  million
Exercisable at December 31, 202512,029,819 53.92 4 years$55  million
 
(1)Cash received from options exercised was $94 million in 2025, $175 million in 2024 and $152 million in 2023. The excess income tax benefit from stock option exercises was $7 million in 2025, $19 million in 2024 and $21 million in 2023.
Performance Share Units and Deferred Stock Units
We recorded compensation expense related to PSUs and DSUs of $87 million in 2025, $117 million in 2024 and $121 million in 2023 in our results from continuing operations. The deferred tax benefit recorded related to this compensation expense was $14 million in 2025, $19 million in 2024 and $18 million in 2023. The unamortized compensation expense related to our PSUs and DSUs was $129 million at December 31, 2025 and is expected to be recognized over a weighted-average period of 1.8 years.

Our PSU and DSU activity is reflected below:
Number
of Shares
Weighted-Average
Fair Value
Per Share (3)
Weighted-Average
Aggregate
Fair Value
Balance at January 1, 20234,451,674 $60.12 
Units granted:
Performance share units (1)
1,312,820 67.48 
Deferred stock units
926,288 65.99 
Total units granted (1)
2,239,108 66.86 $150  million
Vested (1) (2)
(1,772,439)61.92 $110  million
Forfeited
(365,177)62.66 
Balance at December 31, 20234,553,166 62.53 
Units granted:
Performance share units (1)
1,517,643 67.76 
Deferred stock units
930,655 72.35 
Total units granted (1)
2,448,298 69.50 $170  million
Vested (1) (2)
(2,075,329)58.51 $121  million
Forfeited
(389,561)66.91 
Balance at December 31, 20244,536,574 67.76 
Units granted:
Performance share units (1)
1,438,015 67.95 
Deferred stock units
1,443,758 63.19 
Total units granted (1)
2,881,773 65.56 $189  million
Vested (1) (2)
(1,562,811)63.29 $99  million
Forfeited
(518,412)69.30 
Balance at December 31, 20255,337,124 67.73 

(1)Includes incremental PSUs issued over target.
(2)The income tax shortfall upon vesting of PSUs and DSUs was $1 million in 2025 and the excess tax benefit upon vesting of PSUs and DSUs was $7 million in 2024 and $3 million in 2023.
(3)The grant date fair value of PSUs is determined based on the Monte Carlo simulation model for the market-based total shareholder return component and the closing market price of the Company’s stock on the grant date for performance-based components. The Monte Carlo simulation model incorporates the probability of achieving the total shareholder return market condition. Compensation expense is recognized using the grant date fair values regardless of whether the market condition is achieved, as long as the requisite service has been provided.